IIB Alum Marco L. Davila, MD, PhD, to Present Talk at Duke
Marco L. Davila, MD, PhD, of Roswell Park Comprehensive Cancer Center, will present, “Mechanisms of Toxicity and Treatment Resistance to CD19- targeted CART cells” at Duke Cancer Institutes’ Seminar Series on Wednesday, January 22, 2025, at 8AM.
Study in Mice Links Immune System to ADHD, Neurobehavioral Conditions
Building on research that has linked immune responses with certain neurobehavioral conditions, researchers at Duke Health have identified how a key infection-fighting function is involved in triggering hyperactive behaviors in mice
Joshua Hatterschide awarded NIH Individual Postdoctoral Fellowship
Joshua Hatterschide of Carolyn Coyne's Lab was awarded a prestigious F32 grant from the National Institute of Environmental Health Sciences (NIEHS).
PhD candidate Agastya Sharma awarded NIH F31 grant
Agastya Sharma's Fellowship application was awarded from the NIH after receiving a perfect score. Agastya is currently a Molecular Genetics and Microbiology grad student in the lab of Raphael Valdivia.
PhD candidate Naren Mehta awarded NIH F31 grant
On November 27th, Naren Mehta of Maria Ciofani's lab was awarded a highly prestigious F31 grant from the The National Institutes of Health, supporting 3 years of funding.
Stacy Horner featured in Cell Press webinar Nov. 15
Faculty member Stacy Horner will be one of three guests presenting at the 2023 Cell Press webinar, "RNA sensing in immunity".
New Mouse Model Discovered to Study Granuloma Response
Carissa Harvest working in the Miao lab described a new mouse model to study how granulomas, cellular fortresses built around foreign objects, kill pathogens.
Ciofani Lab Mouse Study Yields Potential New Target to Combat Multiple Sclerosis
Researchers in Maria Ciofani's lab, studying multiple sclerosis in mice, have identified a protein that could reshape the understanding of MS treatments.